Search Results - "Durgun, Meltem Ezgi"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Polymeric-Micelle-Based Delivery Systems for Nucleic Acids by Sinani, Genada, Durgun, Meltem Ezgi, Cevher, Erdal, Özsoy, Yıldız

    Published in Pharmaceutics (26-07-2023)
    “…Nucleic acids can modulate gene expression specifically. They are increasingly being utilized and show huge potential for the prevention or treatment of…”
    Get full text
    Journal Article
  2. 2

    Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery by Batur, Eslim, Özdemir, Samet, Durgun, Meltem Ezgi, Özsoy, Yıldız

    Published in Pharmaceuticals (Basel, Switzerland) (01-04-2024)
    “…Ocular drug delivery poses unique challenges due to the complex anatomical and physiological barriers of the eye. Conventional dosage forms often fail to…”
    Get full text
    Journal Article
  3. 3

    Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies by Durgun, Meltem Ezgi, Mesut, Burcu, Hacıoğlu, Mayram, Güngör, Sevgi, Özsoy, Yıldız

    Published in Pharmaceutics (27-02-2022)
    “…Fungal ocular infections can cause serious consequences, despite their low incidence. It has been reported that Posaconazole (PSC) is used in the treatment of…”
    Get full text
    Journal Article
  4. 4

    Nanofibers in Ocular Drug Targeting and Tissue Engineering: Their Importance, Advantages, Advances, and Future Perspectives by Uzel, Egemen, Durgun, Meltem Ezgi, Esentürk-Güzel, İmren, Güngör, Sevgi, Özsoy, Yıldız

    Published in Pharmaceutics (25-03-2023)
    “…Nanofibers are frequently encountered in daily life as a modern material with a wide range of applications. The important advantages of production techniques,…”
    Get full text
    Journal Article
  5. 5

    Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies by Durgun, Meltem Ezgi, Kahraman, Emine, Hacıoğlu, Mayram, Güngör, Sevgi, Özsoy, Yıldız

    Published in Drug delivery and translational research (01-03-2022)
    “…Posaconazole (PSC) is a triazole group anti-fungal agent with the widest spectrum. Although there is no commercially available ocular dosage form, its diluted…”
    Get full text
    Journal Article
  6. 6